GlassScriptPhysician profile
Leo Edelsberg
NPI 1851302020
$4,264.99
in general payments reported to CMS, 2019-2025
20 companies · $648 in 2025
The $648 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,095 · 2020: $47.31 · 2021: $630 · 2022: $868 · 2023: $384 · 2024: $594 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $874.95 | 2022-2025 | Infuse, Multi-Focal Lens |
| Johnson & Johnson Vision Care, INC. | $828.65 | 2021-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $398.13 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $261.93 | 2019-2020 | |
| Dompe US, INC. | $261.52 | 2024-2025 | Oxervate |
| Alcon Vision LLC | $244.76 | 2021-2025 | Precision7 |
| Genzyme Corporation | $243.59 | 2019-2022 | |
| Rxsight INC | $168.93 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Apellis Pharmaceuticals, INC. | $124.99 | 2023 | |
| Shire North American Group INC | $124.76 | 2019 | |
| Allergan, INC. | $124.16 | 2019 | |
| Aerie Pharmaceuticals, INC. | $112.92 | 2019 | |
| Coopervision INC. | $106.82 | 2019 | |
| Optos, INC. | $96.77 | 2019 | |
| Lkc Technologies, INC. | $85.76 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59.71 | 2024 | |
| Oyster Point Pharma, INC. | $50.00 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $49.46 | 2025 | Xdemvy |
| Glaukos Corporation | $27.78 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Edelsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.